Unusual Case of Ischemic Colitis Caused by Low-Dose Sumatriptan Therapy in a Generally Healthy Patient After Strenuous Physical Activity.

ischemic colitis large bowel necrosis migraine disorder serotonin agonists sumatriptans

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 11 08 2021
entrez: 17 9 2021
pubmed: 18 9 2021
medline: 18 9 2021
Statut: epublish

Résumé

Ischemic colitis refers to an inflammatory condition of the large bowel caused by ischemia. It usually presents with an acute onset abdominal pain followed by hematochezia. It can occur as a result of arterial occlusion (embolic or thrombotic), venous thrombosis, or hypoperfusion of mesenteric circulation secondary to dehydration, surgery, or medications. Herein, we present an unusual case of sumatriptan-induced ischemic colitis. Sumatriptan succinate is a selective serotonin (5-hydroxytryptamine-1) receptor agonist that is usually prescribed for refractory migraine headaches. This is a 59-year-old female who presented with acute onset abdominal pain followed by bloody diarrhea after vigorous physical activities. She has a past medical history of non-specific colitis (one time, 15 years ago) and chronic migraine for which she was on low-dose sumatriptan therapy (one tab once or twice a week). On the day of the event, the patient took sumatriptan in the morning and had strenuous activities throughout the day, and overnight she developed abdominal pain. It was followed by bouts of bloody diarrhea. The colonoscopy revealed erythematous mucosa with significant ulceration and necrosis involving the distal transverse colon, splenic flexure, descending colon, and proximal colon, suggestive of ischemic colitis. Unlike previously reported cases, this patient was only on low-dose sumatriptan therapy without frequent dosing. So, her risk of ischemic colitis from triptan therapy could have been accelerated by excessive sweating and strenuous physical activities. The patient was treated with intravenous hydration, bowel rest, intravenous antibiotics, and withdrawal of sumatriptan and her condition improved within the next two to three days.

Identifiants

pubmed: 34532167
doi: 10.7759/cureus.17125
pmc: PMC8434802
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e17125

Informations de copyright

Copyright © 2021, Tin et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Hepatogastroenterology. 2014 Mar-Apr;61(130):336-42
pubmed: 24901136
Drugs. 1998 Jun;55(6):889-922
pubmed: 9617601
Surgery. 2003 Oct;134(4):624-9; discussion 629-30
pubmed: 14605623
Radiology. 1996 Jun;199(3):632-6
pubmed: 8637978
Am J Gastroenterol. 2010 Oct;105(10):2245-52; quiz 2253
pubmed: 20531399
Neurology. 2004 Feb 24;62(4):563-8
pubmed: 14981171
Arch Intern Med. 1998 Sep 28;158(17):1946-8
pubmed: 9759693
Dis Colon Rectum. 2005 Dec;48(12):2313-6
pubmed: 16228819
World J Gastroenterol. 2010 Sep 28;16(36):4564-9
pubmed: 20857527
Am J Gastroenterol. 2015 Jan;110(1):18-44; quiz 45
pubmed: 25559486
Dig Dis Sci. 2009 Sep;54(9):2009-15
pubmed: 19089615
Colorectal Dis. 2012 Nov;14(11):e751-63
pubmed: 22776101

Auteurs

Swann Tin (S)

Internal Medicine, Richmond University Medical Center, Staten Island, USA.

William Lim (W)

Internal Medicine, Richmond University Medical Center, Staten Island, USA.

Rushaniya Umyarova (R)

Internal Medicine, Richmond University Medical Center, Staten Island, USA.

Marutha Arulthasan (M)

Internal Medicine, Richmond University Medical Center, Staten Island, USA.

Magda Daoud (M)

Internal Medicine/Gastroenterology, Richmond University Medical Center, Staten Island, USA.

Classifications MeSH